The US market for stroke devices will grow strongly through 2026 as a result of the adoption of innovative devices as well as the establishment of dedicated infrastructure for stroke treatment. 

This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for stroke devices in the US across a 10-year period

The results of the DAWN trial have driven expanded guidelines for the use of neurovascular thrombectomy in the treatment of AIS.

How will the updated guidelines impact market growth?

How much growth is expected in this market?

What factors limit growth of this rapidly expanding market?

An increasing number of small competitors are entering the stroke device market in the US.

How will new entrants change the competitive landscape?

What tactics are smaller companies using to gain share in the market?

Rising adoption of neurovascular thrombectomy procedures for the treatment of AIS is driving infrastructure changes for stroke care in the US.

How will these changes affect the neurovascular thrombectomy device market?

How much will infrastructure growth and change drive the stroke lab system market?

Will the focus on AIS impact interventional hemorrhagic stroke treatments?

Expansion of ICH procedure volumes hinges on obtaining conclusive clinical evidence demonstrating the superior efficacy of neurovascular evacuation devices compared to other treatment options. 

What factors will drive adoption of surgical ICH procedures and devices tailored to those procedures?

Will the reluctance of neurosurgeons to adopt new techniques and devices without strong clinical data impede this market?

How will increasing ICH treatment volumes affect the stroke device market?

Table of contents

  • Stroke Devices - Market Insights - United States

Author(s): Ashish Bhupal, MBA

Ashish Bhupal is a manager within the Cardiovascular Medtech Insights team at DRG (Part of Clarivate), specializing in clot management, vascular access, aortic repair, heart valve, structural heart, interventional oncology, peripheral vascular, neurovascular, and transcatheter embolization and occlusion device markets. Ashish holds a Bachelor's in Biotechnology and an MBA in Biotechnology Management from Amity University, as well as a Six Sigma Green Belt certification from The British Standards Institution.

Follow Ashish on Twitter: @Ashishb_DRG.

Related Reports

Vascular Access Devices - Market Insights - Europe (Supplemental)

The European market for vascular access devices will see slight growth over the forecast period, driven in large part by the rising adoption of ...

View Details

Dialysis Access Treatment Devices - Market Insights - Asia Pacific (Supplemental)

The Asia Pacific dialysis access treatment device market will grow modestly through 2029, driven by rising incidence of ESRD due t...

View Details

Dialysis Access Treatment Devices - Market Insights - Europe (Supplemental)

The European market for dialysis access treatment devices is a dynamic market that will grow moderately through 2029, driven by the availability of novel and innovative products. However, market...

View Details

Neurovascular Devices - Market Insights - US

The COVID-19 pandemic will have a modest impact on the US market for neurovascular devices in the short term. Once the impac...

View Details